PSIL Among Its Peers
End-of-day Nov 19, 2026 · 1 ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −9.8% | −16.8% | −32.4% | +1.9% | +6.5% | +48.5% | −77.3% | — | −79.6% |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$118 of every $1,000 in PSIL is Definium
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics | 11.76% |
| 2 | CMPS | Compass Pathways | 10.59% |
| 3 | HELP | Helus Pharma | 7.13% |
| 4 | LLY | ELI Lilly & | 6.78% |
| 5 | NBIX | Neurocrine Biosciences | 6.42% |
| 6 | ABBV | Abbvie | 6.09% |
| 7 | SUPN | Supernus | 5.45% |
| 8 | SPTX | Seaport Therapeutics | 5.28% |
| 9 | NRXP | NRX Pharmaceuticals | 5.18% |
| 10 | RLMD | Relmada Therapeutics | 4.99% |
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | DFTXDefinium Therapeutics | Healthcare | 11.76% | $1,175.96 | 153K | $4.5M |
| 2 | CMPSCompass Pathways | Healthcare | 10.59% | $1,058.74 | 494K | $4.0M |
| 3 | HELPHelus Pharma | Healthcare | 7.13% | $712.57 | 392K | $2.7M |
| 4 | LLYELI Lilly | Healthcare | 6.78% | $678.29 | 1,860 | $2.6M |
| 5 | NBIXNeurocrine Biosciences | Healthcare | 6.42% | $642.29 | 15K | $2.4M |
| 6 | ABBVAbbvie | Healthcare | 6.09% | $608.79 | 8,071 | $2.3M |
| 7 | SUPNSupernus | Healthcare | 5.45% | $544.87 | 71K | $2.1M |
| 8 | SPTXSeaport Therapeutics | Healthcare | 5.28% | $527.96 | 109K | $2.0M |
| 9 | NRXPNRX Pharmaceuticals | Healthcare | 5.18% | $517.51 | 701K | $2.0M |
| 10 | RLMDRelmada Therapeutics | Healthcare | 4.99% | $499.34 | 663K | $1.9M |
| 11 | JNJJohnson & Johnson | Healthcare | 4.92% | $492.07 | 6,842 | $1.9M |
| 12 | GHRSGH Research | Healthcare | 4.91% | $491.12 | 102K | $1.9M |
| 13 | ANROAlto Neuroscience | Healthcare | 4.64% | $463.61 | 68K | $1.8M |
| 14 | STIMNeuronetics | Healthcare | 3.62% | $362.18 | 1.1M | $1.4M |
| 15 | DRUGBright Minds Biosciences | Healthcare | 2.64% | $263.99 | 48K | $1.0M |
PSIL has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| PSIL | 0.13 | 0.20 | 39.6% | −34.7% | 1.18 | $128 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $1.68 |
| Sep 22, 2025 | Sep 29, 2025 | $0.0201 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0119 |
| Mar 21, 2025 | Mar 28, 2025 | $0.16 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0548 |
| Sep 23, 2024 | Sep 30, 2024 | $0.11 |
| Sep 25, 2023 | Sep 29, 2023 | $0.34 |
| Sep 26, 2022 | Sep 30, 2022 | $5.41 |